Literature DB >> 19447224

Differential interactions of the catalytic subunits of adenylyl cyclase with forskolin analogs.

Cibele Pinto1, Melanie Hübner, Andreas Gille, Mark Richter, Tung-Chung Mou, Stephen R Sprang, Roland Seifert.   

Abstract

The diterpene forskolin (FS) binds to, and activates, mammalian membranous adenylyl cyclase (AC) isoforms I-VIII. Diterpenes without C(1)-OH group do not activate ACs. The C(1)-OH group forms a hydrogen bond with the backbone oxygen of Val506 of the C1 catalytic subunit of AC (isoform V numbering). To better understand the mechanism of AC activation we examined the interactions of FS and eight FS analogs with purified catalytic AC subunits C1 (AC V) and C2 (AC II) by fluorescence spectroscopy, using 2',3'-O-(N-methylanthraniloyl)-guanosine 5'-triphosphate (MANT-GTP) as fluorescent reporter probe, and by enzymatic activity. FS analogs induced C1/C2 assembly as assessed by fluorescence resonance energy transfer from Trp1020 of C2 to MANT-GTP and by increased direct MANT-GTP fluorescence in the order of efficacy FS approximately 7-deacetyl-FS approximately 6-acetyl-7-deacetyl-FS approximately 9-deoxy-FS>7-deacetyl-7-(N-methylpiperazino-gamma-butyryloxy)-FS>1-deoxy-FS approximately 1,9-dideoxy-FS approximately 7-deacetyl-1-deoxy-FS approximately 7-deacetyl-1,9-dideoxy-FS. In contrast, FS analogs activated catalysis in the order of efficacy FS>7-deacety-FS approximately 6-acetyl-7-deacetyl-FS approximately 9-deoxy-FS>7-deacetyl-7-(N-methylpiperazino-gamma-butyryloxy)-FS>>1-deoxy-FS, 1,9-dideoxy-FS, 7-deacetyl-1-deoxy-FS and 7-deacetyl-1,9-dideoxy-FS (all ineffective). 1-Deoxy-FS analogs inhibited FS-stimulated catalysis by an apparently non-competitive mechanism. Our data suggest a two-step mechanism of AC activation by diterpenes. In the first step, diterpenes, regardless of their substitution pattern, promote C1/C2 assembly. In the second and yet poorly understood step, diterpenes that form a hydrogen bond between C(1)-OH and Val506 promote a conformational switch that results in activation of catalysis. The apparent non-competitive interaction of FS with 1-deoxy-FS analogs is explained by impaired ligand exchange due to strong hydrophobic interactions with C1/C2.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19447224      PMCID: PMC2692545          DOI: 10.1016/j.bcp.2009.03.023

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  23 in total

Review 1.  Catalytic mechanism and regulation of mammalian adenylyl cyclases.

Authors:  W J Tang; J H Hurley
Journal:  Mol Pharmacol       Date:  1998-08       Impact factor: 4.436

Review 2.  Complexity and diversity of mammalian adenylyl cyclases.

Authors:  R K Sunahara; C W Dessauer; A G Gilman
Journal:  Annu Rev Pharmacol Toxicol       Date:  1996       Impact factor: 13.820

3.  Crystal structure of the catalytic domains of adenylyl cyclase in a complex with Gsalpha.GTPgammaS.

Authors:  J J Tesmer; R K Sunahara; A G Gilman; S R Sprang
Journal:  Science       Date:  1997-12-12       Impact factor: 47.728

4.  Interactions of forskolin and ATP with the cytosolic domains of mammalian adenylyl cyclase.

Authors:  C W Dessauer; T T Scully; A G Gilman
Journal:  J Biol Chem       Date:  1997-08-29       Impact factor: 5.157

5.  Interaction of Gsalpha with the cytosolic domains of mammalian adenylyl cyclase.

Authors:  R K Sunahara; C W Dessauer; R E Whisnant; C Kleuss; A G Gilman
Journal:  J Biol Chem       Date:  1997-08-29       Impact factor: 5.157

6.  Structural basis for the inhibition of mammalian membrane adenylyl cyclase by 2 '(3')-O-(N-Methylanthraniloyl)-guanosine 5 '-triphosphate.

Authors:  Tung-Chung Mou; Andreas Gille; David A Fancy; Roland Seifert; Stephen R Sprang
Journal:  J Biol Chem       Date:  2004-12-09       Impact factor: 5.157

7.  Determining the potency and molecular mechanism of action of insurmountable antagonists.

Authors:  Terry Kenakin; Stephen Jenkinson; Christian Watson
Journal:  J Pharmacol Exp Ther       Date:  2006-07-20       Impact factor: 4.030

8.  Broad specificity of mammalian adenylyl cyclase for interaction with 2',3'-substituted purine- and pyrimidine nucleotide inhibitors.

Authors:  Tung-Chung Mou; Andreas Gille; Srividya Suryanarayana; Mark Richter; Roland Seifert; Stephen R Sprang
Journal:  Mol Pharmacol       Date:  2006-06-09       Impact factor: 4.436

9.  Forskolin carbamates: binding and activation studies with type I adenylyl cyclase.

Authors:  J D Robbins; D L Boring; W J Tang; R Shank; K B Seamon
Journal:  J Med Chem       Date:  1996-07-05       Impact factor: 7.446

10.  Activation and inhibition of adenylyl cyclase isoforms by forskolin analogs.

Authors:  Cibele Pinto; Dan Papa; Melanie Hübner; Tung-Chung Mou; Gerald H Lushington; Roland Seifert
Journal:  J Pharmacol Exp Ther       Date:  2008-01-09       Impact factor: 4.030

View more
  8 in total

1.  Interactions of Bordetella pertussis adenylyl cyclase toxin CyaA with calmodulin mutants and calmodulin antagonists: comparison with membranous adenylyl cyclase I.

Authors:  Dominik Schuler; Carolin Lübker; Gerald H Lushington; Wei-Jen Tang; Yuequan Shen; Mark Richter; Roland Seifert
Journal:  Biochem Pharmacol       Date:  2012-01-13       Impact factor: 5.858

2.  Differential inhibition of various adenylyl cyclase isoforms and soluble guanylyl cyclase by 2',3'-O-(2,4,6-trinitrophenyl)-substituted nucleoside 5'-triphosphates.

Authors:  Srividya Suryanarayana; Martin Göttle; Melanie Hübner; Andreas Gille; Tung-Chung Mou; Stephen R Sprang; Mark Richter; Roland Seifert
Journal:  J Pharmacol Exp Ther       Date:  2009-06-03       Impact factor: 4.030

3.  Structure-activity relationships for the interactions of 2'- and 3'-(O)-(N-methyl)anthraniloyl-substituted purine and pyrimidine nucleotides with mammalian adenylyl cyclases.

Authors:  Cibele Pinto; Gerald H Lushington; Mark Richter; Andreas Gille; Jens Geduhn; Burkhard König; Tung-Chung Mou; Stephen R Sprang; Roland Seifert
Journal:  Biochem Pharmacol       Date:  2011-05-18       Impact factor: 5.858

4.  Effect of MANT-nucleotides on L-type calcium currents in murine cardiomyocytes.

Authors:  Melanie Hübner; Sara Dizayee; Jan Matthes; Roland Seifert; Stefan Herzig
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2011-04-12       Impact factor: 3.000

Review 5.  Inhibitors of membranous adenylyl cyclases.

Authors:  Roland Seifert; Gerald H Lushington; Tung-Chung Mou; Andreas Gille; Stephen R Sprang
Journal:  Trends Pharmacol Sci       Date:  2011-11-17       Impact factor: 14.819

6.  Isoform selectivity of adenylyl cyclase inhibitors: characterization of known and novel compounds.

Authors:  Cameron S Brand; Harrison J Hocker; Alemayehu A Gorfe; Claudio N Cavasotto; Carmen W Dessauer
Journal:  J Pharmacol Exp Ther       Date:  2013-09-04       Impact factor: 4.030

7.  Impact of divalent metal ions on regulation of adenylyl cyclase isoforms by forskolin analogs.

Authors:  Miriam Erdorf; Tung-Chung Mou; Roland Seifert
Journal:  Biochem Pharmacol       Date:  2011-08-06       Impact factor: 5.858

Review 8.  International Union of Basic and Clinical Pharmacology. CI. Structures and Small Molecule Modulators of Mammalian Adenylyl Cyclases.

Authors:  Carmen W Dessauer; Val J Watts; Rennolds S Ostrom; Marco Conti; Stefan Dove; Roland Seifert
Journal:  Pharmacol Rev       Date:  2017-04       Impact factor: 25.468

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.